High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas.

MLA

Le Gouvello, S., et al. “High Prevalence of Foxp3 and IL17 in MMR-Proficient Colorectal Carcinomas.” Gut, vol. 57, no. 6, June 2008, pp. 772–79. EBSCOhost, https://doi.org/10.1136/gut.2007.123794.

APA

Le Gouvello, S., Bastuji-Garin, S., Aloulou, N., Mansour, H., Chaumette, M.-T., Berrehar, F., Seikour, A., Charachon, A., Karoui, M., Leroy, K., Farcet, J.-P., & Sobhani, I. (2008). High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas. Gut, 57(6), 772–779. https://doi.org/10.1136/gut.2007.123794

Chicago

Le Gouvello, S, S Bastuji-Garin, N Aloulou, H Mansour, M-T Chaumette, F Berrehar, A Seikour, et al. 2008. “High Prevalence of Foxp3 and IL17 in MMR-Proficient Colorectal Carcinomas.” Gut 57 (6): 772–79. doi:10.1136/gut.2007.123794.